Substance
ID:341335
Names and Identifiers
IUPAC Traditional name
indole, 5-nitro
IUPAC name
5-nitro-1H-indole
Synonyms
5-Nitroindole5-硝基吲哚NSC 520594
Registration numbers
CAS Number
MDL Number
Beilstein Number
EC Number
PubChem SID
Properties
Safety Information
GHS Pictograms
Corrosive to metals, category 1
Skin corrosion, categories 1A,1B,1C
Serious eye damage, category 1
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
Risk Statements
22-41
German water hazard class
3
GHS Precautionary statements
P280-P305+P351+P338
GHS Hazard statements
H302-H318
GHS Signal Word
Danger
European Hazard Symbols
Harmful (Xn)Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Safety Statements
26-39
MSDS Link
RTECS
NM1168200
Product Information
Purity
98%
Empirical Formula (Hill Notation)
C8H6N2O2
Physical Property
Melting Point
140-142 °C(lit.)
Molecule Details
Packaging
25 g in poly bottle
5 g in glass bottle
Application
Reactant for preparation of:
• Pharmaceutically active 2-oxo-1-pyrrolidine analogues1
• Tryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles as potential anticancer immunomodulators2
• Protein Kinase Inhibitors and antiproliferative agents3
• Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 (mGlu4)4
• Antifungal agents5
• Cannabinoid receptor type 1 (CB1) antagonists6
• Potential anticancer agents7
• Potential antivascular agents8
• Selective Anti-leukemic agents9
• Anti human immunodeficiency virus subtype 1 (HIV-1) agents10
25 g in poly bottle
5 g in glass bottle
Application
Reactant for preparation of:
• Pharmaceutically active 2-oxo-1-pyrrolidine analogues1
• Tryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles as potential anticancer immunomodulators2
• Protein Kinase Inhibitors and antiproliferative agents3
• Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 (mGlu4)4
• Antifungal agents5
• Cannabinoid receptor type 1 (CB1) antagonists6
• Potential anticancer agents7
• Potential antivascular agents8
• Selective Anti-leukemic agents9
• Anti human immunodeficiency virus subtype 1 (HIV-1) agents10
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data